The World Market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients, 2024-2030
June 11, 2024 11:23 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Oral Solid Dosage Forms (OSDF) and Pharma Excipients - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
June 11, 2024 06:00 ET
|
NMD Pharma
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel...
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma
June 11, 2024 02:00 ET
|
Essential Pharma
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma Egham, UK and Copenhagen,...
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
June 11, 2024 01:00 ET
|
NMD Pharma
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing...
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry: 1-Day Online Training Course (October 14, 2024) with Theory, Activities, Exercises, and Practical Applications
June 10, 2024 09:38 ET
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course" conference has been added to ...
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...
Flexible Plastic Packaging Market to accrue USD 250 Billion by 2032, Says Global Market Insights inc.
June 10, 2024 04:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 10, 2024 (GLOBE NEWSWIRE) -- Flexible Plastic Packaging Market is anticipated to record USD 250 billion by the end of 2032, as per a recent study by Global Market Insights...
$14 Billion Virtual Reality (VR) Neuropsychological Therapy Market (2024-2034) by Technology, Offering, End-user and Region Featuring Profiles of Oculus VR (Facebook Technologies), MindMaze, Psious, and More
June 07, 2024 04:19 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global Virtual Reality Neuropsychological Therapy Market" report has been added to ResearchAndMarkets.com's offering.The global virtual reality...
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
June 06, 2024 10:00 ET
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...